Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jeong Yun Ya"'
Autor:
Christina P. Wang, Meg McKinley, Annie Vu, Jeong Yun Yang, Samir Gupta, Scarlett L. Gomez, Michelle Kang Kim, Steven H. Itzkowitz, Shailja C. Shah
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 4, Pp 482-490 (2024)
Background and Aims: Gastrointestinal cancer incidence varies by race and ethnicity. In the United States (US), there are screening guidelines for esophageal cancer (EC) and colorectal cancer (CRC), but not gastric cancer (GC). We compared GC, CRC, a
Externí odkaz:
https://doaj.org/article/d807e3a74adf4287bfea5385b3d5199c
Autor:
Sheila D. Rustgi, Aaron Oh, Jeong Yun Yang, Dasol Kang, Edward Wolin, Chung Y. Kong, Chin Hur, Michelle K. Kim
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background & Aims Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are heterogeneous neoplasms. Although some have a relatively benign and indolent natural history, others can be aggressive and ultimately fatal. Somatostatin analogues
Externí odkaz:
https://doaj.org/article/4221a750cab84bb4b137da0bbd395a5b
Autor:
Jeong Yun Ya, Sang-Mun Chon, Myungsun Kim, Kim Boo Deuk, Min-Ho Jung, Hong Lee, Young-Ho Kim, Don Winning, Do Young Kim, Young-Hoon Kim, Beom-Sang Yoo, Sangwoong Yoon, Eun-Soon Chung
Publikováno v:
SPIE Proceedings.
There are many considerations to the design of BARC materials. Among those many properties, one important property that can effect lithographic performance is BARC coating uniformity. In general, the basic coating property (conformal or planar) depen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78a007130fae671a33e556be4f395c9d
https://doi.org/10.1117/12.533924
https://doi.org/10.1117/12.533924
Autor:
Katherine Ni, Jeong Yun Yang, Kiwoon Baeg, Amanda C. Leiter, Grace Mhango, Emily J. Gallagher, Juan P. Wisnivesky, Michelle K. Kim
Publikováno v:
Cancer Reports, Vol 4, Iss 5, Pp n/a-n/a (2021)
Abstract Background Gastroenteropancreatic neuroendocrine tumors (GEP‐NETs) are increasingly common malignancies and tend to have favorable long‐term prognoses. Somatostatin analogues (SSA) are a first‐line treatment for many NETs. Short‐term
Externí odkaz:
https://doaj.org/article/a6cebf31b54741498ce606b2d923ff2f